Form 4: GoodRx Executive Romin Nabiey Reports Stock Transactions

Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, Inc., reported the acquisition and disposal of Class A Common Stock and Restricted Stock Units on February 8, 2025.

Summary

• On February 8, 2025, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., engaged in transactions involving the company's stock.
• Nabiey acquired 12,662 shares of Class A Common Stock through the vesting of Restricted Stock Units.
• Nabiey also disposed of 5,202 shares of Class A Common Stock to cover tax obligations at a price of $4.84 per share.
• Following these transactions, Nabiey directly owns 99,439 shares of Class A Common Stock and 113,965 Restricted Stock Units.
• The reported transactions were filed with the SEC on February 11, 2025.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is standard practice for publicly traded companies. It provides transparency into the trading activities of insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading.
• The vesting schedule of the restricted stock units (6.25% initially, then quarterly installments) is a common equity compensation structure.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
• The disposal of shares to cover tax obligations is a common practice and is unlikely to significantly affect the company's stock price.

Key Dates

Keywords

GoodRx Holdings, GDRX, Romin Nabiey, Chief Accounting Officer, SEC Form 4, Stock Transactions, Class A Common Stock, Restricted Stock Units, Beneficial Ownership